Predicting outcomes after 177Lu-PSMA therapy in castration-resistant prostate cancer

被引：0
|
作者：
Hindie, Elif [1 ]
机构：
[1] CHU Bordeaux, Dept Nucl Med, Hop Haut Leveque, Ave Magellan, F-33604 Pessac, France
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E425 / E425
页数：1
相关论文
共 50 条
  • [31] From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
    Al-Ibraheem, Akram
    Abdlkadir, Ahmed Saad
    Sweedat, Deya' Aldeen
    Maus, Stephan
    Al-Rasheed, Ula
    Salah, Samer
    Khriesh, Fadi
    Juaidi, Diyaa
    Abu Dayek, Dina
    Istatieh, Feras
    Anwar, Farah
    Asrawi, Aisha
    Abufara, Alaa
    Al-Rwashdeh, Mohammad
    Abu-Hijlih, Ramiz
    Sharaf, Baha'
    Ghanem, Rami
    Abdel-Razeq, Hikmat
    Mansour, Asem
    [J]. CANCERS, 2024, 16 (11)
  • [32] Lu-177 PSMA Radioligand Therapy as Salvage Treatment in Metastatic Castration-Resistant Prostate Cancer
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Langbein, T.
    Zhang, J.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S287 - S288
  • [33] Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer
    Mader, Nicolai
    Schoeler, Christina
    Pezeshkpour, Niloufar
    Klimek, Konrad
    Groener, Daniel
    Happel, Christian
    Tselis, Nikolaos
    Mandel, Philipp
    Gruenwald, Frank
    Sabet, Amir
    [J]. CANCERS, 2023, 15 (18)
  • [34] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    [J]. AKTUELLE UROLOGIE, 2022, 53 (02)
  • [35] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [36] Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results
    Ozkan, Ahu
    Ucar, Burcu
    Seymen, Huelya
    Yarar, Yasemin Yildiz
    Falay, Fikri Okan
    Demirkol, Mehmet Onur
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : 288 - 291
  • [37] Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Feuerecker, Benedikt
    Chantadisai, Maythinee
    Allmann, Anne
    Tauber, Robert
    Allmann, Jakob
    Steinhelfer, Lisa
    Rauscher, Isabel
    Wurzer, Alexander
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    d'Alessandria, Calogero
    Eiber, Matthias
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 833 - 839
  • [38] Radioligand Therapy with 177Lu-PSMA in Metastatic Castration Resistant Prostate Cancer Patients: First case series in Iran
    Aryana, K.
    Moghadam, S. Zarehparvar
    Divband, G. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S649 - S650
  • [39] Case report. Administration of 177Lu-PSMA in a patiënt with metastatic castration-resistant prostate carcinoma
    van Kalmthout L.W.M.
    Braat A.J.A.T.
    Krijger G.C.
    Ververs T.F.
    de Roos R.
    de Keizer B.
    Lam M.G.E.H.
    [J]. Tijdschrift voor Urologie, 2018, 8 (Suppl 2) : 16 - 18
  • [40] Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
    Gafita, Andrei
    Heck, Matthias M.
    Rauscher, Isabel
    Tauber, Robert
    Cala, Lisena
    Franz, Charlott
    D'Alessandria, Calogero
    Retz, Margitta
    Weber, Wolfgang A.
    Eiber, Matthias
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (10) : 1476 - 1483
12345